Researchs
-
An Open-label Safety Study of Dipraglurant in Patients with Parkinson's Disease Receiving Levodopa-based Therapy With or Without Concomitant Dopaminergic Medications
-
An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
-
ASK-PD5-CS201
-
CurePSP Center of Care
-
SAGE-324-ETD-202
-
Study of the Oral Treatment MTR-601 in Cervical Dystonia
-
A multicenter phase 2, double-blind, placebocontrolled, randomized, parallel-group study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of UCB0022 in study
-
A 6-month prospective, randomized, double-blind, placebo-controlled clinical trialinvestigating the efficacy, safety and tolerability of two different doses of buntanetap orplacebo
-
58-WEEK OPEN-LABEL TRIAL OF TAVAPADON IN PARKINSON'S DISEASE (TEMPO-4 TRIAL)
-
Environmental, Microbial and Mammalian Biomolecular Responses to AhR Ligands
-
Gestational Hyperandrogenism in Cardiovascular Programming
-
Perivascular Adipose Tissue (PVAT) as a Central Integrator of Vascular Health
-
Trpa1 in cognition and brain connectivity
-
Towards scalable production of palatable and nutritious cultured meat using edible, tunable scaffolds
-
Disrupting the vicious cycle: Effects of Montmorency tart cherry supplementation on sleep and inflammation among individuals with overweight and obesity
-
Pilot study of gut microbiome composition and outcomes to interpersonal psychotherapy treatment for depression among adults in Uganda
-
Culture-specific neurodevelopmental assessment of HIV-affected children: Home-Based Evaluation through Cloud-Readiness Enhancement
-
Building Resources to Assess Impaired Neurocognition in Children with HIV in Low- and Middle-Income Countries (BRAIN Child in LMICs)
-
Gut permeability and variations in bio-available vitamin D as mechanisms of adverse cognitive development in HIV-affected & controls children - Anested Pilot Study
-
Vitamin D and Gut Microbiota and Dementia Risk in Older Adults with Chronic HIV infection and Demographically Matched Community Controls